August 5th, 2024

New biomaterial regrows damaged cartilage in joints

Northwestern University researchers created a bioactive material that regenerates knee cartilage, tested in sheep, potentially preventing knee replacements and treating osteoarthritis by promoting durable hyaline cartilage growth.

Read original articleLink Icon
New biomaterial regrows damaged cartilage in joints

Northwestern University researchers have developed a new bioactive material that successfully regenerates high-quality cartilage in knee joints, as demonstrated in a large-animal model. This innovative material, which resembles a rubbery substance, mimics the natural environment of cartilage and promotes repair in damaged areas. In a study published in the Proceedings of the National Academy of Sciences, the material was applied to cartilage defects in sheep, leading to the growth of new cartilage containing essential biopolymers like collagen II and proteoglycans. The researchers believe this therapy could address significant clinical needs, potentially preventing the need for knee replacement surgeries and treating conditions such as osteoarthritis and sports injuries. The material consists of a bioactive peptide that binds to transforming growth factor beta-1 and modified hyaluronic acid, which is naturally found in cartilage. The study's lead researcher, Samuel I. Stupp, emphasized the importance of using a sheep model due to its similarities to human cartilage, which is notoriously difficult to regenerate. The new approach aims to regenerate hyaline cartilage, which is more durable than fibrocartilage produced by current surgical methods. Future applications may include use during open-joint or arthroscopic surgeries, offering a long-term solution for joint pain and mobility issues.

- Northwestern University has developed a bioactive material that regenerates cartilage in knee joints.

- The material was tested in sheep, showing significant cartilage repair within six months.

- It could potentially prevent knee replacements and treat degenerative diseases like osteoarthritis.

- The new approach aims to regenerate durable hyaline cartilage rather than fibrocartilage.

- The study highlights the importance of using large-animal models for predicting human treatment outcomes.

Related

Computer-designed proteins guide stem cells to form blood vessels

Computer-designed proteins guide stem cells to form blood vessels

Researchers at the University of Washington developed computer-designed proteins to guide stem cells in forming blood vessels, showing promise in regenerative medicine for organ repair. The study highlights potential advancements in tissue development research.

Mapping the biology of spinal cord injury in unprecedented detail

Mapping the biology of spinal cord injury in unprecedented detail

EPFL researchers develop 'Tabulae Paralytica' atlas using AI and molecular mapping to study spinal cord injuries in mice. Identifies key genes, challenges astrocyte roles, and highlights Vsx2 neurons for recovery. Published in Nature, the study offers insights for potential gene therapy.

Self-healing 'living skin' can make robots more humanlike

Self-healing 'living skin' can make robots more humanlike

Researchers have developed self-healing "living skin" for robots using cultured skin cells and silicone. This innovative method enhances robots' appearance and functionality, mimicking human skin's healing process. The skin attaches securely with v-shaped hooks, improving aesthetics and durability. Published in Cell Reports Physical Science, this advancement could revolutionize robotics and medical treatments.

Bone tissue reparation using coral and marine sponges

Bone tissue reparation using coral and marine sponges

Bone tissue regeneration has advanced using coral and marine sponges as scaffolds, mimicking bone structure. Surgeons insert them with stem cells, promoting natural healing without stress-shielding, revolutionizing bone surgery.

New gene therapy approach shows promise for Duchenne muscular dystrophy

New gene therapy approach shows promise for Duchenne muscular dystrophy

Researchers at Indiana University developed a new gene therapy for Duchenne muscular dystrophy using a triple-adeno-associated virus vector to deliver a complete dystrophin protein, showing promise in mouse models.

Link Icon 1 comments